Erlonat Tablets - 100mg And 150mg Dosage | Effective Kinase Inhibitor For Lung And Pancreatic Cancer Treatment

We are manufacturing and supplying of Erlonat Tablets (Erlotinib Tablets) from Mumbai, Maharashtra, India. which is a Kinase inhibitor which is primarily used to treat cell lung cancer, or pancreatic cancer when combined with a certain other medicine. It works by inhibiting growth to adjacent tissues in the body so that the cancerous cells slow down, allowing the patient a better environment to recover and fight the cancer naturally.

Dosage and Administration:

Typically, an adult patient will be instructed to take between 100mg and 150mg of Erlonat (Erlotinib), at least 1 hour before any meals or snacks and 2 hours after. Unless otherwise instructed, you should always swallow each tablet whole without chewing, crushing, splitting, or dissolving the tablet in liquid. Wash tablets down with full glass of water.


Side effects:

Patients using Erlonat (Erlotinib) may experience the following side effects. Notify your physician promptly if you notice any side effects, whether listed below or not.
Coughing
Fever
Weakness
Chest pains
Severe or persistent nausea
Vomiting
Diarrhea
Eye discomfort
Irritated or dry skin
Inward growing eyelashes
Unusual bruising or bleeding
Loss of appetite